# Amlodipine + Valsartan

## Exforge 5/80mg

| TAH Drug Code      | [OEXF](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OEXF){:target="_blank"}                                                                                                                                                                            |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension                                                                                                                                                                                                                                                      |
| Dosing             | HTN initial: 1tablet QD slowly titiate up to 2 tablet QD (maximum 10mg/160mg)                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                     |
| Contraindications  | ■Severe hepatic impairment, biliary cirrhosis or cholestasis. Severe renal impairment (GFR <30 mL/min/1.73 m2) & dialysis patients. Pregnancy. ■hypersensitivity to amlodipine, valsartan, or any other component ■concomitant aliskiren use in diabetic patients |
| Adverse Effects    | Common: Peripheral edema (5.4%), Dizziness (2.1%), Nasopharyngitis (4.3%), Upper respiratory infection (2.9%) Serious: Hypotension (0.4%)                                                                                                                         |
| Pregnancy          | Human Data Suggest Risk in 2nd and 3rd Trimesters                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amlodipine-and-valsartan-drug-information){:target="_blank"}                                                                                                                                                         |

